BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients.
Saved in:
| Title: | BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients. |
|---|---|
| Authors: | Pérez-Calvo, Fernando1 (AUTHOR), Jover-Diaz, Francisco1,2 (AUTHOR) fjover@umh.es, Delgado-Sánchez, Elisabet2 (AUTHOR), Peris-García, Jorge1,2 (AUTHOR), Bernabéu-Martínez, María Ángeles3 (AUTHOR), Carradori, Simone (AUTHOR) simone.carradori@unich.it |
| Source: | AIDS Research & Treatment. 12/12/2025, Vol. 2025, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20901240 |
|---|---|
| DOI: | 10.1155/arat/8818830 |
